Jordan Lateiner

Jordan Lateiner is an accomplished professional with over 20 years of experience in the pharmaceutical and biotechnology industry. Specializing in project and portfolio management, asset leadership, clinical development and operations, Jordan has a proven track record of successfully leading cross-functional teams and managing complex drug development programs from concept to market. For nearly 6 years he led the drug development efforts of Ubrelvy (ubrogepant) and Qulipta (atogepant) from Phase II through commercialization across Actavis, Allergan and AbbVie. Over a similar period he also served as Executive Director of Project Management at Allergan overseeing a large CNS drug portfolio and managing a team of exceptional Project Managers that drove multiple products into later stages of development. He joined TrialSpark in early 2022 as VP of Program Management as one of their first “R&D” hires to build out their transition from CRO to Sponsor.

Jordan holds a BS in Exercise Physiology from the University at Buffalo (SUNY), an MS in Neuroscience from Penn State University and an MBA in Healthcare Administration from Baruch College (CUNY)/Mt. Sinai School of Medicine. Jordan is also a certified Project Management Professional (PMP).